首页> 外文期刊>BMC Infectious Diseases >Pneumococcal carriage and antibiotic susceptibility patterns from two cross-sectional colonization surveys among children aged <5 years prior to the introduction of 10-valent pneumococcal conjugate vaccine — Kenya, 2009–2010
【24h】

Pneumococcal carriage and antibiotic susceptibility patterns from two cross-sectional colonization surveys among children aged <5 years prior to the introduction of 10-valent pneumococcal conjugate vaccine — Kenya, 2009–2010

机译:在引进10价​​肺炎球菌缀合物疫苗前<5年前的儿童两种横截面殖民化调查的肺炎球菌携带和抗生素易感性模式 - 肯尼亚,2009-2010

获取原文
           

摘要

Background Pneumococci are spread by persons with nasopharyngeal colonization, a necessary precursor to invasive disease. Pneumococcal conjugate vaccines can prevent colonization with vaccine serotype strains. In 2011, Kenya became one of the first African countries to introduce the 10-valent pneumococcal conjugate vaccine (PCV10) into its national immunization program. Serial cross-sectional colonization surveys were conducted to assess baseline pneumococcal colonization, antibiotic resistance patterns, and factors associated with resistance. Methods Annual surveys were conducted in one urban and one rural site during 2009 and 2010 among children aged Results Of 1,087 enrolled (Kibera: 740, Lwak: 347), 90.0% of these were colonized with pneumococci, and 37.3% were colonized with PCV10 serotypes. There were no differences by survey site or year. Of 657 (of 730; 90%) isolates tested for antibiotic susceptibility, nonsusceptibility to cotrimoxazole and penicillin was found in 98.6 and 81.9% of isolates, respectively. MDR was found in 15.9% of isolates and most often involved nonsusceptibility to cotrimoxazole and penicillin; 40.4% of MDR isolates were PCV10 serotypes. In the multivariable model, PCV10 serotypes were independently associated with penicillin nonsusceptibility (Prevalence Ratio: 1.2, 95% CI 1.1–1.3), but not with MDR. Conclusions Before PCV10 introduction, nearly all Kenyan children aged
机译:背景技术肺炎球菌被鼻咽殖民化的人蔓延,侵袭性疾病的必要前体。肺炎球菌缀合物疫苗可以防止疫苗血清型菌株的定植。 2011年,肯尼亚成为第一个将10价肺炎球菌共轭疫苗(PCV10)纳入其国家免疫计划的非洲国家之一。进行串联横截面殖民化调查,以评估基线肺炎球菌定植,抗生素抗性模式和与抗性相关的因素。方法在2009年和2010年中,在1,087岁的儿童中,在1,087名(Kibera:740,Lwak:347)中,每年进行年度调查,其中90.0%用肺炎球菌殖民,37.3%用PCV10血清型殖民。调查网站或年份没有差异。在98.6和81.9%的分离物中发现了657(730; 90%)分离株,对Cotrimoxazole和青霉素的非排尿剂感染。 MDR被发现在15.9%的分离物中,最常涉及对Cotrimoxazole和青霉素的非排尿剂; 40.4%的MDR分离物是PCV10血清型。在多变量模型中,PCV10血清型与青霉素非空白(患病率比率:1.2,95%CI 1.1-1.3)独立相关,但不能与MDR进行。在PCV10引言之前,几乎所有肯尼亚儿童

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号